Quotient Sciences Ltd:製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Quotient Sciences Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C11242)・商品コード:DATA904C11242
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:32
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Quotient Sciences Ltd (Quotient Sciences), formerly Pharmaceutical Profiles Group Ltd is a drug development service provider. The company offers services such as formulation development, clinical trial manufacturing, clinical pharmacology, and commercial manufacturing services. Its formulation development services include formulation design, pre-formulation screening, first-in-human to proof of concept, analytical services, and process optimization and scale up. Quotient Sciences’ clinical trial manufacturing services comprise phase I and II clinical trial manufacturing, real-time adaptive manufacturing, and global supply management. The company caters its services to the pharmaceutical and biotech industry. It has operations in the US and the UK. Quotient Sciences is headquartered in Nottingham, the UK.

Quotient Sciences Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Quotient Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Quotient Sciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Quotient Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Quotient Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Quotient Sciences Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Quotient Sciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Quotient Sciences Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Quotient Clinical Acquires GMP Manufacturing Facility 11
Private Equity 12
GHO Capital Partners Acquires Quotient Clinical from Bridgepoint Development Capital 12
Bridgepoint Development Capital Acquires Quotient Clinical From Quotient Bioresearch 13
Partnerships 14
Pharmaceutical Product Development Enters into Agreement with Quotient Sciences 14
Quotient Clinical Enters into Agreement Nuformix 15
Corcept Therapeutics Enters into Agreement with Quotient Clinical 16
Corcept Therapeutics Enters into Agreement with Quotient Clinical for CORT122928 17
Highland Therapeutics Enters into Agreement with Quotient Clinical 18
Corcept Therapeutics Enters into Agreement with Quotient Clinical for CORT125134 19
Quotient Clinical Enters Into Agreement With Pulmatrix For PUR0200 20
Acquisition 21
Quotient Sciences Acquires Pharmaterials 21
Quotient Clinical Acquires QS Pharma from Charles River Labs 22
Quotient Clinical Acquires Seaview Research 23
Quotient Sciences Ltd – Key Competitors 24
Quotient Sciences Ltd – Key Employees 25
Quotient Sciences Ltd – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Strategy And Business Planning 28
Nov 05, 2018: Quotient Sciences significantly expands formulation and manufacturing operations in U.K. 28
Oct 16, 2018: Growth quotient sciences constructs state-of-the-art early-phase formulation and manufacturing facility in U.S. 29
Corporate Communications 30
May 30, 2017: Quotient Clinical Appoints Azhar Kalim as Chief Commercial Officer 30
Other Significant Developments 31
Nov 10, 2017: Quotient Sciences Launches as the New Global Identity for Quotient Clinical 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Quotient Sciences Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Quotient Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Quotient Sciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Quotient Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Quotient Sciences Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Quotient Sciences Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Quotient Sciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Quotient Clinical Acquires GMP Manufacturing Facility 11
GHO Capital Partners Acquires Quotient Clinical from Bridgepoint Development Capital 12
Bridgepoint Development Capital Acquires Quotient Clinical From Quotient Bioresearch 13
Pharmaceutical Product Development Enters into Agreement with Quotient Sciences 14
Quotient Clinical Enters into Agreement Nuformix 15
Corcept Therapeutics Enters into Agreement with Quotient Clinical 16
Corcept Therapeutics Enters into Agreement with Quotient Clinical for CORT122928 17
Highland Therapeutics Enters into Agreement with Quotient Clinical 18
Corcept Therapeutics Enters into Agreement with Quotient Clinical for CORT125134 19
Quotient Clinical Enters Into Agreement With Pulmatrix For PUR0200 20
Quotient Sciences Acquires Pharmaterials 21
Quotient Clinical Acquires QS Pharma from Charles River Labs 22
Quotient Clinical Acquires Seaview Research 23
Quotient Sciences Ltd, Key Competitors 24
Quotient Sciences Ltd, Key Employees 25
Quotient Sciences Ltd, Other Locations 26
Quotient Sciences Ltd, Subsidiaries 26

List of Figures
Quotient Sciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Quotient Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Quotient Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Quotient Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Quotient Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Quotient Sciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Quotient Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Quotient Sciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Quotient Sciences Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★調査レポート[Quotient Sciences Ltd:製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C11242)販売に関する免責事項を必ずご確認ください。
★調査レポート[Quotient Sciences Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆